Back to search

Article

A Procoagulant Peptide Analog of the SARS-CoV-2 Nucleocapsid C-terminal Domain

2026-07-07

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Uncontrolled bleeding complicates trauma, surgery and many medical conditions. While currently available procoagulant therapies ( e . g ., plasma-derived factors, recombinant proteins, antifibrinolytics) have crucial limitations. <h4>Methods</h4> N389 (CQQTVTLLPAADLDDFSC) was synthesized by Fmoc solid-phase chemistry, characterized by HPLC and LC–MS, then tested in norma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7fef5d7a-b518-59bd-a651-8d7d8639a05d
DOI
10.64898/2026.07.04.736500
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Procoagulant Peptide Analog of the SARS-CoV-2 Nucleocapsid C-terminal DomainDOI 10.64898/2026.07.04.736500
Select a neighboring publication to make it the new centre.